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1. Introduction
Arteriovenous fistula is an abnormal connection between a feeding artery and an adjacent vein.
It can be congenital, acquired or created (e.g., brachial arteriovenous fistula for haemodialysis
access). When it is pathological, its symptoms and diagnosis differ from one site to another in
the human body.
Spinal vascular malformations (SVM) are rare diseases in comparison to vascular malforma‐
tions of the brain. Spinal dural arteriovenous fistulas (SDAVFs), also known as Type I spinal
arteriovenous malformations, account for 70% of spinal vascular malformations, and are the
most common vascular malformations of the spinal cord and its surrounding dura mater;
however, they remain relatively under-diagnosed. The majority of SDAVFs occur spontane‐
ously, but a post-traumatic aetiology cannot be excluded in a significant proportion of them
(Aghakhani N et al., 2008).
Hebold and Gaupp are credited with the first descriptions of isolated spinal cord vascular
malformation in 1885 and 1888, respectively.
The first detailed clinical and pathological description of what is most likely to represent
SDAVF is found in the 1926 report by Foix and Alajouanine.
Only recently did Kendall and Logue report the first case of an SDAVF as a distinct entity.
Merland et al.15 illustrated the anatomical and pathological structure and location of an
SDVAF in the dura mater and the intradural site of a radicular pouch. Finally, McCutcheon et
al. worked on the anatomical characteristics of SDAVFs.
© 2013 Nachanakian et al.; licensee InTech. This is an open access article distributed under the terms of the
Creative Commons Attribution License (http://creativecommons.org/licenses/by/3.0), which permits
unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Diagnosis of SDAVFs is very difficult in clinical practice. In fact, symptoms are generally
nonspecific.
Typically, this disease affects male patients in their 50s and 60s, causing progressive weakness
of the lower limbs. Only 1% of patients are younger than 30 years of age. Most SDAVFs are
solitary lesions, located between T6 and L2. Together, cervical and sacral SDAVF constitute
fewer than 6% of cases. Multiple lesions in the same patient can exist, but this is rare.
2. Classification of SDAVF
According to the Spetzler classification, spinal vascular lesions can be subdivided into
neoplasms, aneurysms and arteriovenous lesions. Arteriovenous lesions are further classified
as arteriovenous fistulas and AVMs (Table 1).
fistulas and AVMs (Table 1). 
    Hemangioblastoma 
Neoplastic vascular lesion  
     
Cavernous malformations 
 
Aneurysms 
 
    Arteriovenous malformations 
Arteriovenous fistulas              Extradural 
    Arteriovenous fistulas     
          
         Ventral 
     
       Intradural 
         Dorsal 
 
Table 1. Spetzler Classification of Spinal Vascular Malformation
Arteriovenous fistulas can either be extradural or intradural. Extradural arteriovenous fistulas
have also been called epidural fistulas, and consist of a shunt between an extradural artery
and a vein. Myelopathy may occasionally develop because of vascular steal (Arnaud et al.,
1994a; Goyal et al., 1999).
Intradural arteriovenous fistulas are lesions causing progressive myelopathy. They may be
located ventrally or dorsally. In dorsal intradural arteriovenous fistulas (SDAVF, Type I), the
abnormal connection is formed between an artery and a vein at the level of a dural root sleeve
with low flow, in contrast to the high-flow ventral type of fistulas. Ventral intradural arterio‐
venous fistulas consist of a shunt between the anterior spinal artery and an enlarged venous
draining system (Djindjian et al., 1977). Type I fistulas are fed by radicular arteries and are
low-pressure and low-flow vascular shunts. They are located within the dural sleeve of a nerve
root and rarely entail haemorrhage; they are more commonly associated with myelopathy.
Type II fistulas are located within the spinal cord itself and are true pial AVMs. They are high-
pressure and high-flow shunts that are typically supplied by feeders off the anterior or
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posterior spinal artery or the vertebral artery. These fistulas can be associated with myelopathy
or haemorrhage. Type III SDAVFs are also high-flow shunts, derived from any feeding arteries
but extending both intra- and extra-durally. They are extremely rare, but also difficult to treat
because of their size. Type IV SDAVFs are perimedullary fistulas, with variable flow and
pressure, which can be associated with myelopathy or haemorrhage (Table 2).
Type Characteristics Flow
I Direct fistula in dural sleeve of nerveroot Low pressure, low flow
II Intramedullary High flow, high pressure
III Intra & extramedullary paraspinaljuvenile High pressure
IV Intradural extramedullary direct fistula Low to high pressureMedium to high flow
Table 2. Classification of Arteriovenous fistula.
3. Evolution from embryology to pathology
3.1. Embryology of spinal vasculature
Embryological development of the spinal vasculature occurs in four stages. The primitive
segmental stage starts in the second week of gestation. 31 pairs of segmental vessels originate
from paired dorsal aortas and move towards the neural tube along the developing nerve roots.
Segmental vessels divide into ventral and dorsal branches and form capillary networks on the
ventrolateral surface of the neural tube. These networks develop into paired primitive ventral
arterial tracts, precursors of an anterior spinal artery (K. Jellema et al., 2006).
The initial stage starts in the third week. At this level, dorsal arteries anastomose with the
longitudinal venous channel dorsally and ventrally.
The transitional stage follows the initial stage in the sixth week of gestation. At this stage,
fusion of ventral long arterial tracts and a decrease in segmental arteries occur. At ten weeks
we have the adult pattern of spinal vasculature.
Finally, the terminal stage starts after the fourth month. This stage is characterized by the
maturation and increase of the tortuosity of major spinal vessels.
3.2. Anatomy of spinal vasculature
The radiculomeningeal arteries are branches of the segmental arteries (thoracic intercostal in
the thoracic spine, lumbar arteries in the lumbar spine and branches of the vertebral, the deep
cervical and ascending cervical arteries in the cervical spine), supplying the dura in the spinal
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canal, and are found at almost every spinal level. They should be distinguished from the
radiculomedullary arteries, which exist only at some levels and supply the anterior and
posterior spinal arteries that perfuse the spinal cord.
The venous drainage of the spinal cord does not parallel the arterial supply like the extrinsic
arterial system; the extrinsic venous system has two parts: (a) longitudinal trunks, and (b) a
pial plexus, termed the coronal venous plexus. The main arterial supply, the anterior spinal
artery, is on the anterior surface of the cord, whereas the major venous channel is on the
posterior surface, the posterior median vein. This longitudinal trunk vein has a midline
location, whereas the relatively small posterior arterial trunks are off midline. In the thoraco‐
lumbar region, there is usually just one large anterior and one or two large posterior medullary
veins, measuring up to 1.5 mm, accompanying lower thoracic or upper lumbar roots (Tadie
M et al., 1985).
3.3. Pathophysiology of SDAVF
The onset in middle age suggests that SDAVF is an acquired condition, in contrast to intradural
ventral fistulas or AVMs, which are assumed to be congenital abnormalities (Rosenblum et al.,
1987). There are several other differences between SDAVF and AVMs. An SDAVF is never
located within the spinal parenchyma. Patients with SDAVF very rarely suffer spinal haemor‐
rhage. There are no associated vascular lesions in SDAVF. Intradural AVMs occur much more
often in the cervical region (Rosenblum et al., 1987).
Aminoff and others proposed in 1974 that venous hypertension, rather than vascular steal,
cord compression or haemorrhage, was the main pathophysiological factor (Aminoff et al.,
1974). The shunt is most often formed within the dorsal surface of the dural root sleeve in the
intervertebral foramen, where the radicular vein pierces the dura, together with one or more
dural branches of the radicular artery. However, the shunt is sometimes situated along the
dura between two adjacent nerve roots (Berenstein et al., 2004).
The increased pressure causes the venous system to ‘arterialize’, that is, the walls of intrame‐
dullary veins become thickened and tortuous. The radicular feeding artery is often a dural
branch and, in a minority of cases, the medullary artery.
An increase in arterial pressure during the operation directly leads to an increase in venous
pressure (Hassler et al., 1989), which may explain why some patients report that symptoms
become worse after physical activity (Aminoff and Logue, 1974a; Khurana et al., 2002). Apart
from the increased pressure caused by the shunt, the venous outflow may be less efficient to
start with than is the case in healthy individuals (Merland et al., 1980; Thron, 2001).
The lower thoracic region has relatively fewer venous outflow channels at a segmental level
than the cervical or lumbosacral region (Tadie et al., 1985). These differences in segmental
outflow probably contribute to the phenomenon whereby venous congestion is transmitted in
a caudo-cranial direction throughout the spinal cord, and to the fact that the first symptoms
of myelopathy tend to reflect dysfunction of the lowest part of the cord, that is, the conus
medullaris, even though the shunt is at the thoracic level. Possibly arteriovenous shunts are
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not uncommon but they become symptomatic only through congenital or environmental
factors that lead to impairment of venous outflow.
The typical pathophysiologic mechanism of SDAVF is spinal cord venous hypertension, which
is caused by the presence of one or a few small low-flow arteriovenous shunts between a
radiculomeningeal artery and a radiculomedullary vein, usually located in the intervertebral
foramen within the dura.
Thus, SDAVFs are supplied by meningeal branches that do not perfuse the spinal cord,
excluding arterial steal as an associated mechanism. The SDAVF drains via a radiculomedul‐
lary vein (almost always dorsal to the cord) into the perimedullary venous system, ultimately
coalescing with normal spinal cord venous drainage in a retrograde fashion. The venous
drainage of the DAVF is slow and extensive along the spinal veins, and may reach the cervical
spinal canal and the cranial fossa in an ascending fashion and the veins of the cauda equina in
a descending fashion (Patsalides et al., 2011).
The radiculomedullary veins draining the spinal cord venous flow to the epidural space are
not anatomically numerous, and SDAVF is often associated with thrombosis of radiculome‐
dullary and epidural veins. That explains why in SDAVF a low-flow arteriovenous shunt
induces high venous pressure while in congenital high-flow arteriovenous malformations
venous hypertension has fewer physiopathological consequences. The pressure in the vein
draining the SDAVF rises to two thirds of the mean arterial pressure, resulting in venous
hypertension, which then leads to decreased arteriovenous gradient and decreased venous
drainage of the spinal cord parenchyma.
Due to the slow-flow characteristics of SDAVFs, haemorrhage rarely occurs. Even though the
pathophysiology of SDAVFs located on the cervical dura is similar to DAVFs in the thoraco‐
lumbar area, they may cause spinal subarachnoid haemorrhage or intracranial haemorrhage
if there is venous reflux towards the brain.
3.4. Clinical presentation
Symptoms consist of myelopathy and radiculopathy and can mimic a polyradiculopathy or
anterior horn cell disorder. Symptoms can progress to paraparesis or quadriparesis.
At first, almost all patients report back or leg pain with mild sensory dysfunction. Then
symptoms progress slowly until diagnosis (Diaz R J et al., 2008). The mean time from the initial
onset of symptoms is 15 to 23 months. In general, upper motor neuron lesion manifestations
are dominant. Progressive weakness, muscle spasms, faecal incontinence, overflow urinary
incontinence or urinary retention and erectile dysfunction are characteristic of myelopathy,
but they are not specific to spinal dural arteriovenous fistula (Jellema K et al., 2006).
3.5. Deferential diagnosis
The differential diagnosis of nontraumatic progressive myelopathy is broad (K. Jellema, et al.,
2006). The most urgent diagnoses to exclude are compressive neoplasm and infection with a
spinal epidural abscess. However, other causes of increased MRI T2 cord signal are intrame‐
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dullary tumours, degenerative disc disease, inflammatory and autoimmune conditions,
infections, vascular disorders, and nutritional and toxic causes. Intradural tumours can be
primary or metastatic and are found in the intramedullary or extramedullary space. Myelop‐
athy due to cervical spondylosis is the most common cause of nontraumatic spastic paraparesis
and quadriparesis. Lumbar canal stenosis is also common in this age group and can contribute
to gait dysfunction, thus complicating the diagnosis. Myelitis can be acute (as seen in postviral
infection or demyelinating myelitis) but can also be subacute to chronic conditions (e.g., AIDS
myelopathy, syphilis). Inflammation of the spinal cord also occurs in several rheumatologic
and connective tissue diseases, which may precede the onset of systemic symptoms by years.
16 Nutritional deficiencies should be considered in patients with gastrointestinal disease, a
history of gastric bypass surgery, or a history of exposures to toxins that prevent adequate
absorption of nutrients.
The time course, patient age, comorbidities, systemic symptoms, presence or absence of
peripheral nervous system involvement, and localization to tracts or regions within the spinal
cord can help narrow the extensive differential diagnosis for progressive myelopathy.
Many aetiologies are easily excluded by history, imaging (e.g., tumours), and serum and
cerebrospinal fluid analysis (e.g., infections). However, the nonspecific features of SDAVF and
frequency of both upper motor neuron signs (increased muscle tone and deep tendon reflexes)
and lower motor neuron signs (flaccid weakness, depressed deep tendon reflexes) can delay
diagnosis, particularly in older adults who are likely to have comorbid systemic diseases and/
or cervical spondylosis. Failure to respond to standard therapy for other causes of myelopathy
should trigger further investigation.
3.6. Imaging
The essential investigations to establish the diagnosis are MRI and catheter angiography,
which should be performed when a progressive myelopathy is suspected. MRI findings
include hypo-intensities on T1-weighted images and hyperintensities on T2-weighted images.
Increased signal intensity in the centre of the spinal cord and peripheral sparing on T2-
weighted images is found in 67–100% of patients (Figure. 1) (Bowen et al., 1995; Hurst and
Grossman, 2000; Luetmer et al., 2005).
In addition,  abnormalities suggesting abnormal blood vessels may be seen on either the
ventral  or the dorsal  side of the spinal cord.  These ‘flow void phenomena’ representing
tortuous and dilated veins at the dorsal surface of the spinal cord are found in 35–91% of
patients (Hurst and Grossman, 2000). It seems that the flow voids are found more often,
as studies are more recent, which may reflect advancement in MR techniques (Hurst and
Grossman, 2000). The central hyperintense lesions are sometimes difficult to interpret, and
may resemble anterior spinal artery infarction, myelitis  or spinal cord neoplasms (Gran‐
din  et  al.,  1997),  or,  if  slit-like,  a  persistent  central  canal  (Holly  and  Batzdorf,  2002).
Gadolinium-enhanced MRI scanning may reveal some contrast enhancement of the spinal
cord (Terwey et al., 1989).
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MR angiography reveals flow in serpentine perimedullary structures (Bowen et al., 1995;
Binkert et al., 1999; Mascalchi et al., 2001). MR angiography may also give an indication about
the level of the SDAVF, which helps to confine the extent and duration of catheter angiography
(Bowen et al., 1995; Mascalchi et al., 1999; Luetmer et al., 2005).
On the other hand, false positive MR angiography is also possible, in that normal vessels may
be interpreted as being pathologically enlarged (Binkert et al., 1999; Luetmer et al., 2005).
MR TRICKS is a better tool that has improved the diagnosis of SDAVF and reduced the
false positive of MR angiography (Korosec et al., 1996). First introduced by the Universi‐
ty of Wisconsin-Madison group, time resolved imaging of contrast kinetics (TRICKS) is a
method  of  3D  contrast-enhanced  magnetic  resonance  angiography  (MRA)  providing
temporal information. TRICKS combines variable rate k-space sampling, temporal interpo‐
Figure 1. Sagittal T2-weighted images showing intramedullary hyperintensity.
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lation of k-space views, view sharing and zero filling in the slice-encoding dimension. The
interesting aspect  of  the method is  its  ability to acquire a pure arterial  weighted phase;
TRICKS allows ultraresolved 3D contrast-enhanced MRA without  venous contamination
(Albini Ricoli et al., 2007).
Before the introduction of MRI, diagnosis was often made by means of myelography
(Gilbertson et al., 1995). This investigation would show an irregular, varicose dilation of the
lumbar veins, sometimes giving the lumbar roots a ‘postage stamp’ appearance.
Catheter angiography is still the gold standard in the diagnosis of SDAVF (Figure 2). Not only
the intercostal and lumbar arteries should be visualized as potential feeding arteries of an
abnormal shunt, but also the median and lateral sacral artery, the deep cervical and ascending
cervical arteries.
Figure 2. Spinal angiography illustrating a SDAVF fed by right Th11 radicular artery with tortuous draining veins.
The angioarchitecture of the fistula should be thoroughly investigated, especially with regard
to the question of whether the arterial feeder is a dural branch or a segmental medullary artery,
which also contributes to the anterior spinal artery. In the latter case, endovascular treatment
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is not possible, because infarction of the spinal cord is likely to occur. Furthermore, it is essential
to identify the artery of Adamkiewicz, because the fistula may originate from this important
tributary to the anterior spinal artery.
4. Decision making and management
4.1. Diagnostic criteria
The typical patient where SDAVF is suspected is aged 40–80 and shows a gradual onset of
slowly progressive or stepwise worsening myelopathy characterized by lower-extremity
weakness, sensory loss to pinprick and light touch, and late development of bowel and bladder
dysfunction. Pre-operative imaging is mandatory.
MR imaging is an initial diagnostic tool. MRI assesses the level of the suspected SDAVF, shown
by the flow void and the tortuosity of the vessels in addition to intramedullary hyper signal
on a T2-weighted image. MRA can play a valuable role in confirming the diagnosis and
targeting conventional catheter angiography.
All patients with confirmed or suspected SDAVF are evaluated by spinal angiography (Figure
3). After confirming the diagnosis, a joint decision is taken by the neurosurgery team and
endovascular neuroradiology about the method of treatment.
Figure 3. Spinal angiography of the left Th6 radicular artery showing SDAVF with tortuous veins extending superior to
the cervico-thoracic junction level.
Spinal Dural Arteriovenous Fistulas — Treatable Cause of Myelopathy
http://dx.doi.org/10.5772/56725
73
4.2. Indication for surgical treatment
Treatment for SDAVFs must be performed as soon as possible and may be surgical or endo‐
vascular, as both are safe and effective. Microsurgical treatment was considered the gold
standard for many years but recent technical advances in endovascular surgery have made
endovascular treatments an option. As with all inherent disease processes of the spinal cord,
post-operative function is highly related to pre-operative presentation, and maximum
functional results are obtained in patients treated early, before advanced deterioration has
taken place.
4.3. Surgery
4.3.1. Pre-operative work up
All patients admitted to neurosurgery wards are clinically evaluated the day before the
procedure. A full neurological examination is performed evaluating the motor, sensory, and
deep tendon reflexes, as well as the gait. In addition, clinical urological evaluation and, when
needed, urodynamic studies are carried out.
4.3.2. Operative procedure
The procedure is carried out under general anaesthesia. All patients are operated in a prone
position, with the thoracolumbar spine segment in neutral to a slightly kyphotic position,
avoiding hyperlordosis.
Intra-operative motor-evoked potential monitoring is used in all procedures with continuous
observation by the neurologist until the end of the procedure.
The level of the procedure is localized after positioning under fluoroscopy. Midline vertical
skin incision is carried out. The subcutaneous layer and the paraspinal muscles are dissected
until the articular facets are identified.
A two-level laminectomy is carried out. A median longitudinal dural incision is performed,
exposing the intradural nerve root, initial segments of draining vein and several millimetres
of the feeding radicular artery (Figure 4). Intra-operative Doppler control is performed upon
identification of the fistula revealing an arterial spectrum on the redundant dorsal medullary
veins. After the clipping of the feeder of the arteriovenous shunt by a temporary clamp, the
intra-operative monitoring documents a complete disappearance of the arterial spectrum and
the reappearance of the venous pattern. In addition, the motor-evoked potential is monitored
and controlled twice, at a five-minute interval. If no changes are observed in the physiological
studies, the fistula is obliterated at the artery vein connection with two small permanent
vascular clips. Then, it is coagulated (Figure 5).
Dural closure is performed with fascia-latta auto graft using a tight continuous running suture
method. Some trials for synthetic dural graft fail due to a high rate of post-operative CSF leak.
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Figure 4. Pre-operative findings showing tortuous veins with artery under suction tip accompanying the nerve root
beneath the spatula.
4.3.3. Post-operative care
The patient is kept in a completely supine position to avoid CSF leak and is out of bed 48 hours
after surgery. Routine laboratory tests are carried out on day 1. Steroids are applied post-
operatively in high dosages (Methylprednisolone, 1g every 24 hours; or Dexamethasone, 8mg
every 8 hours), and this regime is continued with progressive tapering over two weeks, with
a shift to oral medication in 72 hours. No imaging is ordered in the immediate post-op period,
unless there is a clinical deterioration. A control spine MRI with angiography MR is carried
out six months after the operation.
4.3.4. Long-term results
Overall improvement was noted in surgically treated patients, and to a considerable degree
of satisfaction in approximately 75% of patients. Motor strength and gait improvement were
superior to bladder function (Ropper A E et al., 2012). Deterioration of the previous neuro‐
logical status was found in less than 10% of cases; persistence of stable status was found in 10–
15% of the operated patients (Schick U et al., 2003, Song JK et al., 2001).
Post-operative neurological improvement progressively increased during the next three
months. Patients achieved maximum improvement after an average period of six months. The
prominent characteristic of this surgery is a low level of post-operative pain.
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Motor and gait dysfunction improved more than sensory and bladder dysfunction with time.
Figure 5. Pre-operative finding after clipping of the feeding artery. The image shows early shrinkage of the arterial‐
ized veins.
4.3.5. Complications
In general, this procedure is well tolerated. The overall rate of complications is between 1 and
5%. Two kinds of complications exist: the early and the delayed (Schick U et al., 2003, Song JK
et al., 2001 and Ropper A E et al., 2012).
Early complications include CSF leak, infection, haematoma, and neurological sequelae.
Delayed complications depend on obliteration rate, which is around 98% in surgical patients.
4.4. Endovascular treatment
Endovascular therapy is less invasive than microsurgery, and allows both diagnosis and
treatment in a single session (Park S B et al., 2008); however, more than one session may be
necessary for some patients.
The ability to definitively treat spinal DAVFs using endovascular embolization has signifi‐
cantly improved over the last several decades. Overall rates of definitive embolization of spinal
DAVFs have ranged between 25 and 100%, depending in part on the embolic agent used and
the use of variable stiffness microcatheters. The majority of recent studies in which N-butyl
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cyanoacrylate or other liquid embolic agents were used have reported success rates of 70–90%
(Sivakumar W et al., 2009). Although endovascular therapy is potentially less invasive and
associated with less morbidity and earlier mobilization than surgery, endovascular therapy
has been associated with a lower initial success rate and higher rate of recurrence than
microsurgical therapy (Van Dijk JM et al., 2002). Several factors need to be considered when
selecting endovascular therapy for the treatment of spinal DAVF. A spinal DAVF usually
consists of multiple dural arterial vessels with a single draining vein. Thus, occlusion of a
feeding arterial vessel may lead to recanalization or collateral development in the early post-
operative period (McCutcheon IE et al., 1996). Another important consideration is the identi‐
fication of patients with conditions that would make them unsuitable for endovascular
therapy. Embolization therapy may not be feasible if the arterial feeder is too small to cathe‐
terize and arterial damage due to catheter manipulation is likely, as in patients with severe
arteriosclerosis, or if the anterior spinal artery, the Adamkiewicz and feeding artery of the
fistula originate from the same segmental artery (Thron A, 2001).
Detachable coils, silk sutures, polyvinyl alcohol (PVA), and n-butyl-2-cyanoacrylate (NBCA)
have been used as embolic agents for endovascular management of DAVFs.
The use of liquid embolization material is imperative to prevent recanalization, while the use
of particle embolization (polyvinyl alcohol, embospheres and gel foam) is not indicated
because of its high recanalization rates. At first, N-butyl cyanoacrylate (NBCA) was often used.
Endovascular embolization of SDAVF using NBCA has a high success rate (Warakaulle DR et
al., 2003). It is referred to as glue, being an extremely effective liquid acrylic polymer that
polymerizes when it comes into contact with an ionic medium such as blood. NBCA is diluted
with ethiodized oil to render it radiopaque and visible during the embolization. Transarterial
NBCA embolization is highly operator-dependent because the glue quickly polymerizes, often
leading to inadequate filling of the proximal draining vein. Complete filling of the proximal
vein is a critical component for definitive endovascular cure of these lesions.
At present, the Onyx is used, which is a new liquid embolic agent, a mixture of ethylene-vinyl
alcohol copolymer and dimethyl sulfoxide (DMSO). While DMSO diffuses under aqueous
conditions the ethylene-vinyl alcohol copolymer precipitates and mechanically occludes the
feeding vessels, whose viscosity makes it suitable for treatment of spinal DAVF, where
penetration into the proximal radicular vein is required (Carlson AP et al., 2007; Ross et al.,
2012). Contrary to NBCA, Onyx does not adhere to the biological surfaces, which allows for
slow delivery and improved penetration of the nidus (Nogueira RG et al., 2009).
4.4.1. Endovascular technique
The procedure is carried out under general anaesthesia in an interventional radiology room.
The patient is in a supine position. The right femoral crease is prepared for puncture.
Neurophysiological monitoring allows a warning for the neuroradiologist of impending
irreversible neurological damage so that action may be taken for the prompt restoration of
adequate spinal cord perfusion. Muscle motor-evoked potentials reflect spinal cord perfusion
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in the anterior spinal artery territory better than somatosensory-evoked potentials (SEPs).
Although rarely used, motor-evoked potentials make the procedure safer (Sala F et al., 2001).
After recording baseline SEPs and MEPs, 50 mg of sodium amytal is injected through the
microcatheter at the position of the intended embolization, followed by assessment of SEPs
and MEPs. If no changes have occurred, 40 mg of lidocaine is then injected, followed by
recording of SEPs and MEPs. If no changes are noted again, embolization is performed (Niimi
et al., 2000). If there is any change in either the SEPs or the MEPs, NBCA embolization is not
performed from that catheter position.
After delivery of the embolization material, DMSO leaks from the embolus allowing for Onyx
to precipitate into the vessel lumen. (Figure 6).
 
Figure 6. Left: Arteriography of SDAVF pre embolization. Right: Arteriography of the same patient post embolization.
4.4.2. Post-procedure care
The patient is transferred to a regular ward after the embolization procedure. The post-
operative steroid protocol is identical to the one used in the microsurgery technique (high-
dose steroids for the first two days, then progressive tapering after a shift to per os intake over
two weeks).
The patients ambulate on the first day post-embolization and can be discharged on day 2.
Regular clinical follow-ups are carried out one, three and six months after the procedure. A
new spinal angiography is ordered six months after the endovascular procedure.
4.4.3. Complications
The risk of inadvertent embolization of arteries feeding normal tissue is high, and precise
positioning of the delivery microcatheter as close as possible to the arteriovenous lesion is an
important manoeuvre to prevent embolization of normal tissue. To prevent polymerization in
the delivery catheter or prematurely in the vasculature, the microcatheter must first be
thoroughly flushed. For NBCA solution after mixing with radiopaque solution, the micro‐
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catheter is flushed with 10–15 ml of 5% dextrose solution. On the other hand, the use of Onyx
injection necessitates microcatheter flushing with saline solution to fill the dead space esti‐
mated for 0.5 to 1 ml.
The recanalization rate in all  serious cases is  15–20% (Song et  al.,  2001;  Hall  WA et  al.,
1989). The bleeding rate and/or embolization of inadequate arteries differed between serious
and other cases, fluctuating between 0 and 4% (Schick U and Hassler W, 2003; Steinmetz
MP et al. 2004).
5. Institution experience
Our experience is based on 16 cases of SDAVF treated from January 2003 to March 2012. Eleven
cases were managed surgically, whereas five were treated by endovascular embolization. This
decision was based on age, clinical symptoms, and the level of the fistula.
87.5% of our patients were male. The mean age was 65 years. Three cases were in the lumbar
level, one in the sacral and 12 in the thoracic region. Fifteen cases had a radicular artery feeder,
one had an intercostal feeder and one was identified incidentally during an interlaminar
approach for a herniated disc.
We recorded three cases of radiculopathy in our series. All other patients showing signs of
progressive myelopathy worsened over long-term periods.
In our institution, patients are admitted for 24 hours before the day of the procedure, and as
early as possible after initial diagnosis.
In the pre-operative period, the patient is treated with anti-platelets and other anti-coagulation
agents for five days. Only LMWH can be tolerated up to 12 hours before the procedure.
If the treatment decided upon is surgical, patients ambulate 48 hours after the procedure; those
treated by endovascular embolization ambulate within 24 hours of the procedure.
All patients are assessed using the Aminoff-Logue disability scale in the pre-op and post-op
periods.
Usually, patients have regular follow-ups at one, three and 12 months.
Patients at first reported an improvement of their radicular pain, with a mean reduction of
4.3/10 on visual analogue scale (VAS) (0: absent pain, to 10: severe intolerable pain necessitating
intra-venous treatment). In the pre-operative period, radicular pain when extant had a mean
score of 7.8/10 on VAS; in the immediate post-op period, the pain was 3.4/10 on VAS.
We did not observe any complications in the surgically treated patients, although recanaliza‐
tion occurred in one of the patients treated by embolization. No bleeding or embolization at
other sites was observed.
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6. Conclusion
With progressive myelopathy of unknown origin in a middle-aged patient, SDAVF must
always be considered. Magnetic resonance imaging, especially the new 3T generation, is a good
initial tool to identify the tortuous veins around the spinal cord and spinal cord oedema,
especially on T2WI. Spinal catheter angiography remains the gold standard for diagnosis and
identification of the site of the fistula. These vascular malformations can be treated either by
endovascular embolization or surgical clipping, keeping in mind that the latter has a higher
occlusion rate.
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